U.S. Paper and Forestry Products Stock News

NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

Has QuidelOrtho (QDEL) Become A Potential Opportunity After Its Sharp Share Price Slide

If you are wondering whether QuidelOrtho is starting to look like a value opportunity or a value trap, its current share price means it is a stock where valuation really matters. The share price closed at US$21.93, with a 5.2% decline over 7 days, a 21.9% decline over 30 days, a 23.8% decline year to date and a 46.8% decline over the past year, while the 3-year and 5-year returns stand at a 74.8% decline and an 86.4% decline respectively. Recent news coverage has focused on QuidelOrtho's...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Palomar ESOP Shelf Filing Raises Questions On Share Issuance And Valuation

Palomar Holdings filed a shelf registration for a common stock offering tied to its Employee Stock Ownership Plan. The filing sets up the company to issue shares over time in connection with employee ownership and compensation programs. This move may influence the company’s capital structure and how equity is distributed to employees. For you as an investor looking at NasdaqGS:PLMR, this ESOP linked shelf registration sits alongside a share price of $120.94 and a value score of 3. The stock...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

Corcept Lawsuits Put Relacorilant Setback And Investor Risk In Focus

Multiple shareholder class action lawsuits have been filed against Corcept Therapeutics (NasdaqCM:CORT) after the company disclosed that the FDA issued a Complete Response Letter for relacorilant. Plaintiffs allege Corcept and certain executives misrepresented FDA communications and the likelihood of approval for relacorilant prior to the New Drug Application decision. The lawsuits claim that longstanding regulatory concerns about the clinical evidence for relacorilant were not adequately...
NYSE:SEM
NYSE:SEMHealthcare

Select Medical Take Private Interest Spurs Fresh Look At Valuation Risks

Select Medical Holdings (NYSE:SEM) has received a nonbinding indication of interest to take the company private. A special committee of the Board is currently reviewing the proposal. The approach represents a potential change in ownership structure and corporate control. For shareholders, the timing of this approach comes after a mixed share price record. The stock closed at $14.82, with a 1-year return of a 21.3% decline and a 3-year return of a 6.6% decline. Over 5 years, the share price...
NYSE:AWR
NYSE:AWRWater Utilities

American States Water Keeps ATM Capacity As Funding And Dilution Questions Linger

American States Water (NYSE:AWR) has amended its Equity Distribution Agreement for its at the market equity offering program. Under the amendment, Huntington Securities replaces Janney Montgomery Scott as one of the sales agents. The company still has a significant portion of its authorized shares available for potential issuance under the program. American States Water is a regulated water utility and services provider, so access to cost effective equity funding can matter for long term...
NasdaqGS:COLB
NasdaqGS:COLBBanks

Did Columbia Banking System's (COLB) Dividend Affirmation Quietly Reframe Its Capital Allocation Story?

Earlier this month, Columbia Banking System, Inc. declared a quarterly cash dividend of US$0.37 per common share, payable on March 16, 2026, to shareholders of record as of February 27, 2026. This dividend affirmation, alongside revenue growth of approximately 23.2% as of December 31, 2025 relative to peers, highlights management’s confidence in the bank’s current financial position. With this dividend decision underscoring management’s confidence, we’ll now examine how it interacts with...
NYSE:SNA
NYSE:SNAMachinery

Snap-on Balances Resilient Sales With Higher Dividend And Ongoing Buybacks

Snap-on (NYSE:SNA) reports resilient sales in a challenging environment, supported by strong product innovation and customer response. The company announces a dividend increase for the sixteenth consecutive year. Snap-on confirms continued share repurchases as part of its capital return program. Snap-on, a long established supplier of tools, equipment, and diagnostics to professional users, is leaning on new products and franchisee feedback as it responds to higher material costs and...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Cellebrite DI (CLBT) Is Down 11.7% After Strong 2025 Profit Rebound And 2026 Guidance Update

Cellebrite DI Ltd. recently reported its fourth-quarter and full-year 2025 results, showing revenue rising to US$128.82 million for the quarter and US$475.68 million for the year, alongside a swing from a large prior-year loss to net income of US$78.33 million, and issued 2026 revenue guidance of US$126 million–US$128 million for Q1 and US$565 million–US$571 million for the full year. The move from a basic loss per share of US$1.35 in 2024 to basic earnings per share of US$0.32 in 2025...
NasdaqGS:NDSN
NasdaqGS:NDSNMachinery

How Investors Are Reacting To Nordson (NDSN) Strong Q1 Beat And Raised 2026 Sales Guidance

In February 2026, Nordson Corporation reported first-quarter fiscal 2026 results showing sales of US$669.46 million and net income of US$133.38 million, with diluted earnings per share from continuing operations of US$2.38, all higher than the same period a year earlier. Alongside these results, Nordson raised its full-year 2026 sales guidance to a range of US$2.86 billion to US$2.98 billion, signaling increased management confidence backed by strong demand in areas such as semiconductors...
NasdaqGS:MIDD
NasdaqGS:MIDDMachinery

Assessing Middleby (MIDD) Valuation After Recent Share Price Momentum

Why Middleby is on investors’ radar today Middleby (MIDD) has drawn fresh attention after recent share price moves, with the stock up about 10% over the past month and roughly 37% over the past 3 months. See our latest analysis for Middleby. That recent 30 day share price return of 10% and 90 day gain of 36.82% suggest momentum has picked up, although the 1 year total shareholder return of a 4.87% decline shows longer term holders have not seen the same benefit. If Middleby’s move has you...
NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Newmark Expands Asia Pacific Research Leadership With Singapore Appointment

Newmark Group (NasdaqGS:NMRK) has appointed Shanting Wong as Head of Research in Singapore. The new role is focused on expanding research and analytics coverage across Asia Pacific markets. The appointment reflects the firm’s push to deepen its global research and advisory capabilities. Newmark Group is a global commercial real estate services firm, and research is a core part of how it supports investors, occupiers, and capital markets clients. By adding senior research leadership in...
NYSE:MSA
NYSE:MSACommercial Services

MSA Safety Puts Acquisitions In Focus While Balancing Earnings And Buybacks

MSA Safety (NYSE:MSA) recently highlighted that it is actively pursuing acquisitions to drive inorganic growth. The company’s CEO has put mergers and acquisitions at the forefront, signaling a possible shift in capital allocation priorities. This focus on deal making comes on top of its regular earnings, dividend, and buyback updates. MSA Safety, known for its industrial and personal safety equipment, sits in a segment where scale, product breadth, and customer relationships can matter a...
NasdaqGS:HLIT
NasdaqGS:HLITCommunications

Harmonic Refocuses On Broadband As Partnerships Test Valuation Gap

Harmonic has agreed to sell its Video business to MediaKind, repositioning itself as a pure-play broadband company. The company is integrating its broadband technology with ATX Networks to support cable operators upgrading their networks. A multi-year agreement with izzi in Mexico targets large scale fiber expansion using Harmonic solutions. Harmonic, ticker NasdaqGS:HLIT, is refocusing around broadband at a time when its shares trade at $10.44. The stock shows mixed longer term...
NasdaqGS:BUSE
NasdaqGS:BUSEBanks

A Look At First Busey (BUSE) Valuation As Profitability And Credit Concerns Resurface

Why recent profitability concerns are drawing attention to First Busey Recent commentary around First Busey (BUSE) has focused on a weaker net interest margin and expectations for lower tangible book value per share, raising fresh questions about the bank's profitability and credit quality profile. See our latest analysis for First Busey. At a share price of US$25.48, First Busey has a 30 day share price return of 3.54% and a 1 year total shareholder return of 11.25%. This suggests some...
NYSE:THG
NYSE:THGInsurance

Evaluating Hanover Insurance Group (THG) Valuation After Mixed Short And Long Term Shareholder Returns

Context for Hanover Insurance Group stock Hanover Insurance Group (THG) has drawn investor attention after recent share price moves, with the stock showing mixed short term performance alongside a positive total return over the past year and over a multi year period. See our latest analysis for Hanover Insurance Group. Recent trading has been softer, with a 30 day share price return of 2.4% contrasted against a 90 day share price decline of 6.6%. However, the 1 year total shareholder return...
NYSE:GVA
NYSE:GVAConstruction

Granite Construction (GVA) Is Up 5.9% After Strong 2025 Results And Higher 2026 Outlook - Has The Bull Case Changed?

In February 2026, Granite Construction reported fourth-quarter and full-year 2025 results showing higher sales and net income, affirmed a US$0.13 quarterly dividend, completed a US$185.61 million share repurchase program totaling 10.4% of shares, and was selected by the Nevada Department of Transportation for US$19 million in preconstruction services on the future I-80 East Widening Project. Together with new 2026 revenue guidance of US$4.9 billion to US$5.1 billion, these updates highlight...
NYSE:HWM
NYSE:HWMAerospace & Defense

A Look At Howmet Aerospace’s (HWM) Valuation After Earnings Beat And Higher 2026 Revenue Guidance

Howmet Aerospace (HWM) is back in focus after a fresh earnings update and higher 2026 revenue guidance put its recent share price strength and premium valuation under a brighter spotlight for investors. See our latest analysis for Howmet Aerospace. Those earnings and guidance updates sit alongside a very strong run in the stock, with a 30 day share price return of 21.43% and a 1 year total shareholder return of 100.87%. This suggests momentum has been building as buybacks, debt funded...
NYSE:ESRT
NYSE:ESRTOffice REITs

Do Empire State Realty Trust's New NYC Leases and Buybacks Reshape ESRT's Core Investment Story?

Empire State Realty Trust reported fourth-quarter 2025 results with higher revenue and net income, renewed and expanded major Manhattan leases with tenants including Burlington, TJ Maxx, JP Morgan Chase, and Nespresso, and completed a US$6,000,000 share repurchase program that retired 891,530 shares. In February 2026, the company reinforced its income profile with first-quarter 2026 common and preferred dividends and highlighted a fully New York City-focused portfolio and award-winning...
NYSE:AS
NYSE:ASLuxury

Amer Sports (AS) Margin Expansion Reinforces Bullish Profitability Narratives Despite Premium P/E

Amer Sports (AS) has just wrapped up FY 2025 with fourth quarter revenue of US$2.1 billion and basic EPS of US$0.24, alongside net income of US$131.5 million. The trailing 12 month figures show revenue of US$6.6 billion and EPS of US$0.77. The company has seen quarterly revenue move from US$1.6 billion in Q4 2024 to US$2.1 billion in Q4 2025, while basic EPS shifted from US$0.03 to US$0.24 over the same period. This sets up a story in which higher earnings and a reported 6.5% net margin over...
NYSE:SN
NYSE:SNConsumer Durables

What SharkNinja (SN)'s Earnings Beat, Buyback, and Beauty Tech Push Mean For Shareholders

In February 2026, SharkNinja, Inc. reported higher fourth-quarter and full-year 2025 sales and net income, issued 2026 net sales growth guidance of 10–11%, announced a US$750 million share repurchase program without incurring debt, and launched its Shark SilkiPro™ Straight air straightener targeting inclusive, wet-to-dry styling. The combination of stronger earnings, a flexible buyback authorization, and expansion into beauty technology underscores how SharkNinja is using product innovation...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

A Look At Merit Medical Systems (MMSI) Valuation After Strong Q4 Results And Raised Revenue Guidance

Merit Medical Systems (MMSI) drew investor attention after reporting fourth quarter 2025 results, with US$393.94 million in sales and US$38.01 million in net income, alongside slightly higher full year revenue guidance. See our latest analysis for Merit Medical Systems. At a share price of US$82.43, Merit Medical Systems has seen only modest short term momentum, with a 1 day share price return of 1.00%. Its 1 year total shareholder return of a 19.21% decline contrasts with total shareholder...
NYSE:VNT
NYSE:VNTElectronic

Assessing Vontier (VNT) Valuation As Shares Show Multi‑Period Momentum Without A Single Trigger Event

Setting the scene for Vontier stock Without a single headline event driving attention today, Vontier (VNT) still offers investors a data rich snapshot, with recent share returns, profitability and value metrics all giving clues about how the market currently views the business. See our latest analysis for Vontier. Vontier’s recent 11.0% 1 month share price return and 14.6% 3 month share price return, alongside a 57.8% 3 year total shareholder return, suggests building momentum that investors...
NYSE:MTRN
NYSE:MTRNMetals and Mining

Should Materion’s Profit Rebound and Upbeat 2026 Guidance Shift the Core MTRN Investment Narrative?

In February 2026, Materion Corporation reported past fourth-quarter 2025 sales of US$489.75 million and net income of US$6.57 million, alongside full-year 2025 sales of US$1.79 billion and net income of US$74.82 million, marking a shift from the prior year’s loss. Alongside these stronger results, Materion issued upbeat 2026 earnings guidance targeting earnings per share of US$6.00 to US$6.50, while buyback disclosures showed no recent repurchases under its latest authorization. We’ll now...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Assessing Erasca (ERAS) Valuation After New Pan KRAS Patent Win Through 2043

Patent win puts Erasca’s pan-KRAS program in sharper focus Erasca (ERAS) has secured a new U.S. patent covering its pan-KRAS inhibitor ERAS-4001 and related compositions through at least 2043. This development tightens protection around its RAS-driven cancer pipeline. See our latest analysis for Erasca. The new patent arrives during a strong run in Erasca’s shares, with a 30-day share price return of 36.65% and a 90-day share price return of 334.82%. The 1-year total shareholder return is...